The differential regulation of Smad7 in kidney tubule cells by connective tissue growth factor and transforming growth factor‐beta1
- 7 May 2007
- journal article
- research article
- Published by Wiley in Nephrology
- Vol. 12 (3), 267-274
- https://doi.org/10.1111/j.1440-1797.2007.00788.x
Abstract
Smad7 is an inhibitory Smad that regulates transforming growth factor-beta (TGF-beta) signaling. Connective tissue growth factor (CTGF) is recognized as a potent downstream mediator of the fibrogenic effects of TGF-beta1. SMAD binding sites have been identified in both TGF-beta and CTGF promoters. The effect of CTGF on Smad7 expression and its role in the regulation of Smad7 induced by TGF-beta1 in renal tubular cells is unknown. Human model of proximal tubular cells (HK-2 cells) was used and confirmed using a diabetic rat model. RT-PCR was performed to measure Smad7, TGF-beta1 and Smad2 and ELISA was performed to measure active TGF-beta1. CTGF or TGF-beta1 was silenced in HK-2 cells using siRNA methodology. TGF-beta1 induced Smad7 in a time-dependent manner, peaking at 30 min (P<0.0005) but sustained up to 24 hrs (p<0.005). Conversely, CTGF reduced Smad7, which was maximal at 24 hrs (p<0.05). This was supported by our in vivo data demonstrating that CTGF protein significantly increased while Smad7 mRNA level was reduced in a diabetic rat model. The basal expression level of Smad7 decreased in TGF-beta1 silenced cells compared to cells transfected with non-specific siRNA (p<0.0005). The basal expression level of Smad7 increased in CTGF silenced cells (p<0.05), which was increased by TGF-beta1 (p<0.005). Both mRNA and protein levels of TGF-beta1 decreased in CTGF silenced cells (p<0.05 and p<0.005 respectively) accompanied by reduction in Smad2 mRNA level in CTGF silenced cells. Smad7 is induced rapidly by TGF-beta1 limiting the response to TGF-beta1. CTGF likely plays a key role in promoting TGF-beta1 activity by decreasing the availability of Smad7 and increasing Smad2.Keywords
This publication has 26 references indexed in Scilit:
- Modulation of the TGFβ/Smad signaling pathway in mesangial cells by CTGF/CCN2Experimental Cell Research, 2005
- Protein Kinase Cβ Inhibition Attenuates Osteopontin Expression, Macrophage Recruitment, and Tubulointerstitial Injury in Advanced Experimental Diabetic NephropathyJournal of the American Society of Nephrology, 2005
- Repression of Endogenous Smad7 by SkiPublished by Elsevier BV ,2004
- Cultured tubule cells from TGF-β1 null mice exhibit impaired hypertrophy and fibronectin expression in high glucoseKidney International, 2004
- Smad-dependent and Smad-independent pathways in TGF-β family signallingNature, 2003
- TGF-β and CTGF have overlapping and distinct fibrogenic effects on human renal cellsAmerican Journal of Physiology-Renal Physiology, 2002
- Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-βNature, 2002
- Smad7 Inhibits Fibrotic Effect of TGF-β on Renal Tubular Epithelial Cells by Blocking Smad2 ActivationJournal of the American Society of Nephrology, 2002
- The Low Density Lipoprotein Receptor-related Protein/α2-Macroglobulin Receptor Is a Receptor for Connective Tissue Growth FactorPublished by Elsevier BV ,2001
- Effects of endothelin or angiotensin II receptor blockade on diabetes in the transgenic (mRen-2)27 ratKidney International, 2000